HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sephora

This article was originally published in The Rose Sheet

Executive Summary

Radio ad campaign airing in U.S. cities, including Boston, Chicago, Dallas, Los Angeles, New York, Philadelphia and Washington D.C., feature voice-overs asking "What is Sephora?" followed by a description of the LVMH division's "experience." The radio spots are part of the firm's $25 mil. campaign initiated in October created by DDB New York (1"The Rose Sheet" Sept. 13, p. 7)

You may also be interested in...



Sephora $25 Mil. Campaign Breaking With Web Site, Flagship Store Debut

Sephora is spending $25 mil. in its first major advertising effort to back its soon-to-be-launched upgraded Web site, www.sephora.com, and the long-awaited opening of its 21,000 sq. ft. flagship store in New York City's Rockefeller Center. The LVMH company signed DDB (New York City) to head up the effort. The e-commerce portal will come online Oct. 15.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007453

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel